UNH

Broadcom and other companies have objected to tokenizing their shares under a new regulatory framework.

UNH's Q3 earnings surge and improving margins signal a recovery, but falling membership and elevated utilization raise questions about sustained growth.

UnitedHealth's wild ride inside DIA was not an accident or a manager's call.

As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.

Some beaten-down consumer names are getting a boost as investors pull back from tech stocks.

UnitedHealth's focus on special needs plans, expanded Medicare coverage and improved margins could drive targeted growth in 2027 despite cost challenges.

UnitedHealth Group Incorporated raised its full-year 2026 adjusted EPS guidance to at least $20.50 in its FQ3 2026 earnings report. With this updated guidance, Wall Street estimates for UNH could be conservative, creating the possibility of a upside surprise. However, despite operational progress, profit margins remain well below historical averages and could limit upside in the next ~2 years.

For the third consecutive quarter, UnitedHealth Group NYSE: UNH delivered a beat on both its top and bottom lines. But, as with the company's Q2 2026 report, investors gave the news a lukewarm response.

Q3 adjusted EPS surged 61% to $4.69, while UnitedHealth raised its 2026 adjusted EPS outlook to at least $20.50. Medical care ratio improved 150 basis points to 88.4%, although favorable reserve development contributed approximately 70 basis points. Nine-month operating cash flow reached $25.1 billion, supporting the view that earnings improvement extends beyond accounting adjustments.

UnitedHealth has shed members, slipped 10% in three months, and closed lower on a beat-and-raise quarter.